Cargando…
Very Severe Aplastic Anemia in a 26-Year-Old Male: Implications for Prognosis and Treatment Options
Aplastic anemia (AA) is a hematopoietic stem cell (HSC) disorder characterized by the loss of HSCs, bone marrow failure, and peripheral pancytopenia. AA is classified as very severe (VSAA), severe (SAA), or non-severe (NSAA) based on the severity criteria. This classification system has implications...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590479/ https://www.ncbi.nlm.nih.gov/pubmed/37872935 http://dx.doi.org/10.7759/cureus.45750 |
_version_ | 1785123998081744896 |
---|---|
author | Alobaidi, Ahmed Albadry, Ahmed Murray, Anne |
author_facet | Alobaidi, Ahmed Albadry, Ahmed Murray, Anne |
author_sort | Alobaidi, Ahmed |
collection | PubMed |
description | Aplastic anemia (AA) is a hematopoietic stem cell (HSC) disorder characterized by the loss of HSCs, bone marrow failure, and peripheral pancytopenia. AA is classified as very severe (VSAA), severe (SAA), or non-severe (NSAA) based on the severity criteria. This classification system has implications for the prognosis and treatment options offered to patients. The prognosis of AA has improved over the past several decades with the advancements in supportive care, HSC transplant (HCT), and immunosuppressive therapy (IST). In this report, we present the case of a 26-year-old male diagnosed with VSAA after presenting with severe neutropenia and fever. The patient ultimately underwent HSC transplantation. |
format | Online Article Text |
id | pubmed-10590479 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-105904792023-10-23 Very Severe Aplastic Anemia in a 26-Year-Old Male: Implications for Prognosis and Treatment Options Alobaidi, Ahmed Albadry, Ahmed Murray, Anne Cureus Internal Medicine Aplastic anemia (AA) is a hematopoietic stem cell (HSC) disorder characterized by the loss of HSCs, bone marrow failure, and peripheral pancytopenia. AA is classified as very severe (VSAA), severe (SAA), or non-severe (NSAA) based on the severity criteria. This classification system has implications for the prognosis and treatment options offered to patients. The prognosis of AA has improved over the past several decades with the advancements in supportive care, HSC transplant (HCT), and immunosuppressive therapy (IST). In this report, we present the case of a 26-year-old male diagnosed with VSAA after presenting with severe neutropenia and fever. The patient ultimately underwent HSC transplantation. Cureus 2023-09-22 /pmc/articles/PMC10590479/ /pubmed/37872935 http://dx.doi.org/10.7759/cureus.45750 Text en Copyright © 2023, Alobaidi et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Internal Medicine Alobaidi, Ahmed Albadry, Ahmed Murray, Anne Very Severe Aplastic Anemia in a 26-Year-Old Male: Implications for Prognosis and Treatment Options |
title | Very Severe Aplastic Anemia in a 26-Year-Old Male: Implications for Prognosis and Treatment Options |
title_full | Very Severe Aplastic Anemia in a 26-Year-Old Male: Implications for Prognosis and Treatment Options |
title_fullStr | Very Severe Aplastic Anemia in a 26-Year-Old Male: Implications for Prognosis and Treatment Options |
title_full_unstemmed | Very Severe Aplastic Anemia in a 26-Year-Old Male: Implications for Prognosis and Treatment Options |
title_short | Very Severe Aplastic Anemia in a 26-Year-Old Male: Implications for Prognosis and Treatment Options |
title_sort | very severe aplastic anemia in a 26-year-old male: implications for prognosis and treatment options |
topic | Internal Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590479/ https://www.ncbi.nlm.nih.gov/pubmed/37872935 http://dx.doi.org/10.7759/cureus.45750 |
work_keys_str_mv | AT alobaidiahmed verysevereaplasticanemiaina26yearoldmaleimplicationsforprognosisandtreatmentoptions AT albadryahmed verysevereaplasticanemiaina26yearoldmaleimplicationsforprognosisandtreatmentoptions AT murrayanne verysevereaplasticanemiaina26yearoldmaleimplicationsforprognosisandtreatmentoptions |